Cited 0 times in
Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDON
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:04:16Z | - |
dc.date.available | 2023-06-02T01:04:16Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194632 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDON | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | E.B. Garon | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | A. Luft | - |
dc.contributor.googleauthor | J. Alatorre-Alexander | - |
dc.contributor.googleauthor | S.L. Geater | - |
dc.contributor.googleauthor | D. Trukhin | - |
dc.contributor.googleauthor | S-W. Kim | - |
dc.contributor.googleauthor | G. Ursol | - |
dc.contributor.googleauthor | M. Hussein | - |
dc.contributor.googleauthor | F.L. Lim | - |
dc.contributor.googleauthor | C-T. Yang | - |
dc.contributor.googleauthor | L.H. Araujo | - |
dc.contributor.googleauthor | H. Saito | - |
dc.contributor.googleauthor | N. Reinmuth | - |
dc.contributor.googleauthor | N. Medic | - |
dc.contributor.googleauthor | H. Mann | - |
dc.contributor.googleauthor | X. Shi | - |
dc.contributor.googleauthor | S. Peters | - |
dc.contributor.googleauthor | T.S.K. Mok | - |
dc.contributor.googleauthor | M. Johnson | - |
dc.identifier.doi | 10.1016/j.annonc.2022.02.014 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422001302 | - |
dc.citation.volume | 33 | - |
dc.citation.number | suppl 2 | - |
dc.citation.startPage | S29 | - |
dc.citation.endPage | S30 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(suppl 2) : S29-S30, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.